Universe Pharmaceuticals (UPC) Income Statement (2019 - 2025)
Annual Income Statement report data from Sep 30, 2019 to Sep 30, 2025 for Universe Pharmaceuticals (UPC).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| 2025 | 2024 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
Revenue and COGS | ||||||
Total Revenue | 18B (-22.44%) | 23B (+57260.39%) | 40M (-16.34%) | 48M (+56.29%) | 31M (-7.61%) | 33M |
Cost Of Revenue | 12B (-31.82%) | 17B (+92790.74%) | 18M (-19.46%) | 23M (+36.42%) | 17M (-16.20%) | 20M |
Costof Goods And Services Sold | 12B (-31.82%) | 17B (+92790.74%) | 18M (-19.46%) | 23M (+36.42%) | 17M (-16.20%) | 20M |
Gross Profit | 6.30B (+3.78%) | 6.07B (+27638.24%) | 22M (-13.58%) | 25M (+79.77%) | 14M (+5.07%) | 13M |
Operating Expenses | ||||||
Research And Development | 672M (-77.84%) | 3.03B (+39574.35%) | 7.64M (+39.67%) | 5.47M (+843.10%) | 580K (-6.45%) | 620K |
Selling General And Administrative | 3.75B (+29.69%) | 2.89B (+132452.75%) | 2.18M (-33.94%) | 3.30M (+94.12%) | 1.70M (+16.44%) | 1.46M |
Operating Expenses | 9.22B (-34.59%) | 14B (+48643.48%) | 29M (+146.25%) | 12M (+205.73%) | 3.84M (+5.21%) | 3.65M |
Depreciation And Amortization | 517M (+6.53%) | 486M (+91547.17%) | 530K (+17.78%) | 450K (+9.76%) | 410K (-2.38%) | 420K |
Operating Income | ||||||
Operating Income | -2.92B (-63.64%) | -8.02B (+114142.74%) | -7.02M | 14M (+32.59%) | 10M (+5.13%) | 9.75M |
Ebit | -2.92B (-63.64%) | -8.02B (+114142.74%) | -7.02M | 14M (+32.59%) | 10M (+5.13%) | 9.75M |
EBITDA | -2.40B (-68.16%) | -7.53B (+115987.98%) | -6.49M | 14M (+31.71%) | 11M (+4.82%) | 10M |
Other Income / Expenses | ||||||
Interest Expense | 289M (-4.97%) | 305M (+190225.00%) | 160K (+60.00%) | 100K (-16.67%) | 120K (-7.69%) | 130K |
Net Interest Income | -289.38M (-4.97%) | -304.52M (+190225.00%) | -160.00K (+60.00%) | -100.00K (-16.67%) | -120.00K (-7.69%) | -130.00K |
Other Non Operating Income | -108.04M | 145M (+290860.00%) | 50K (-44.44%) | 90K | -150.00K (+50.00%) | -100.00K |
Net Income | ||||||
Income Before Tax | -3.67B (-54.78%) | -8.12B (+114435.83%) | -7.09M | 14M (+35.45%) | 10M (+4.66%) | 9.65M |
Income Tax Expense | - | 607M (+73887.80%) | 820K (-65.25%) | 2.36M (-7.09%) | 2.54M (+20.95%) | 2.10M |
Net Income From Continuing Operations | -3.67B (-57.92%) | -8.73B (+110232.49%) | -7.91M | 11M (+49.74%) | 7.56M (+0.13%) | 7.55M |
Net Income | -3.67B (-57.92%) | -8.73B (+110232.49%) | -7.91M | 11M (+49.74%) | 7.56M (+0.13%) | 7.55M |
Comprehensive Income Net Of Tax | -4.37B (-41.43%) | -7.47B (+63941.17%) | -11.66M | 13M (+48.57%) | 8.42M (+21.85%) | 6.91M |